Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase - ganciclovir gene therapy

  • Authors:
    • Ann-Marie Määttä
    • Anni Tenhunen
    • Tiina Pasanen
    • Outi Meriläinen
    • Riikka Pellinen
    • Kimmo Mäkinen
    • Esko Alhava
    • Jarmo Wahlfors
  • View Affiliations

  • Published online on: April 1, 2004     https://doi.org/10.3892/ijo.24.4.943
  • Pages: 943-949
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Lung cancer is a group of diseases that are difficult to cure and new treatment modalities, like gene therapy are actively tested to find alternatives for currently used strategies. Herpes simplex virus thymidine kinase/ganciclovir (HSV-TK/GCV) method is one of the most frequently utilized forms of gene therapy and it has been tested on lung cancer, but no systematic study with comparison of different lung cancer types has been published. In this study, we examined in vitro and in vivo how good targets non-small cell lung cancer (NSCLC) cell lines representing adenocarcinoma, squamous cell lung cancer and large cell lung cancer are for adenovirus-mediated HSV-TK/GCV gene therapy. By using an adenovirus vector carrying a fusion gene of HSV-TK and green fluorescent protein (GFP), we found that: a) adenoviruses were efficient gene transfer vehicles for all types of NSCLCs; b) all adenocarcinoma and large cell lung cancer cells were good targets for HSV-TK/GCV therapy, whereas one of the squamous cell carcinoma cell lines was not responsive to the treatment; c) bystander effect played a major role in the success of this gene therapy form; d) subcutaneous tumors representing all three NSCLC types were efficiently treated with adenovirus-mediated HSV-TK/GCV gene therapy. In summary, this form of gene therapy appeared to be efficient treatment for human NSCLC and these results warrant further studies with primary lung cancer cells and orthotopic lung tumor models.

Related Articles

Journal Cover

April 2004
Volume 24 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Määttä, A., Tenhunen, A., Pasanen, T., Meriläinen, O., Pellinen, R., Mäkinen, K. ... Wahlfors, J. (2004). Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase - ganciclovir gene therapy. International Journal of Oncology, 24, 943-949. https://doi.org/10.3892/ijo.24.4.943
MLA
Määttä, A., Tenhunen, A., Pasanen, T., Meriläinen, O., Pellinen, R., Mäkinen, K., Alhava, E., Wahlfors, J."Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase - ganciclovir gene therapy". International Journal of Oncology 24.4 (2004): 943-949.
Chicago
Määttä, A., Tenhunen, A., Pasanen, T., Meriläinen, O., Pellinen, R., Mäkinen, K., Alhava, E., Wahlfors, J."Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase - ganciclovir gene therapy". International Journal of Oncology 24, no. 4 (2004): 943-949. https://doi.org/10.3892/ijo.24.4.943